Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Arabinogalactan synthesis refers to the **biosynthetic pathway responsible for producing arabinogalactans**, which are complex polysaccharides composed primarily of arabinose and galactose. In plants, these polymers are often attached to proteins as **arabinogalactan proteins** (AGPs), playing key roles in cell wall structure, intercellular signaling, plant growth, and development[1][2][3]. The biosynthesis involves a series of enzymatic steps catalyzed by various glycosyltransferases—including galactosyltransferases and arabinosyltransferases—that sequentially add sugar residues onto protein backbones or growing polysaccharide chains[1]. In bacteria such as *Mycobacterium tuberculosis*, **arabinogalactan is an essential component of the cell envelope**, linking peptidoglycan with outer membrane mycolic acids. Disruption of this synthetic pathway compromises bacterial viability; thus, several enzymes involved are validated drug targets for anti-tuberculosis therapy. For example, ethambutol inhibits key transferase enzymes required for proper assembly of the mycobacterial cell wall[5]. **Note:** "Arabinogalactan synthesis" is not a single molecular target but rather a multi-enzyme pathway/process. It does not refer to one specific protein or receptor but encompasses several distinct enzyme activities necessary for polymer construction both in plants and bacteria. Therefore, it is considered an incorrect entry if used as a canonical target name under standard pharmacological conventions—it should be replaced with specific enzyme names such as "Arabinofuranosyltransferase" when precise targeting information is needed. > The compositional complexity... has focused on elucidation... However... emphasis has been shifting to study... identification of enzymes that are essential... To date thirteen enzymes involved in the synthesis ... have been identified...[5]
Inhibition of glycosyltransferase enzymes required for polymer assembly, leading to defective cell wall formation and bacterial death[5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Arabinogalactan synthesis.